4D Pharma PLC
LSE:DDDD
Cash Flow Statement
Cash Flow Statement
4D Pharma PLC
| Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||
| Net Income |
(8)
|
(8)
|
(10)
|
(17)
|
(20)
|
(19)
|
(24)
|
(25)
|
(24)
|
(26)
|
(26)
|
(61)
|
(54)
|
|
| Depreciation & Amortization |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
(0)
|
(0)
|
(0)
|
3
|
3
|
0
|
0
|
1
|
(2)
|
(0)
|
4
|
39
|
34
|
|
| Cash Taxes Paid |
2
|
3
|
1
|
1
|
1
|
3
|
1
|
1
|
1
|
1
|
(2)
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(1)
|
(4)
|
(4)
|
(1)
|
(1)
|
(5)
|
(1)
|
0
|
3
|
2
|
(2)
|
1
|
(6)
|
|
| Cash from Operating Activities |
(9)
N/A
|
(12)
-34%
|
(14)
-11%
|
(14)
-6%
|
(17)
-20%
|
(22)
-31%
|
(23)
-2%
|
(23)
+1%
|
(22)
+5%
|
(22)
-4%
|
(23)
-1%
|
(20)
+11%
|
(25)
-24%
|
|
| Investing Cash Flow | ||||||||||||||
| Capital Expenditures |
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(81)
|
(33)
|
43
|
64
|
2
|
(5)
|
28
|
15
|
10
|
(0)
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(82)
N/A
|
(35)
+57%
|
40
N/A
|
62
+54%
|
0
-99%
|
(6)
N/A
|
27
N/A
|
14
-47%
|
10
-33%
|
(1)
N/A
|
(0)
+65%
|
(0)
+30%
|
(0)
-62%
|
|
| Financing Cash Flow | ||||||||||||||
| Net Issuance of Common Stock |
65
|
30
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
30
|
36
|
28
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
9
|
|
| Other |
(1)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
(4)
|
(5)
|
|
| Cash from Financing Activities |
64
N/A
|
30
-54%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-321%
|
(0)
+81%
|
(0)
N/A
|
(0)
-2 473%
|
20
N/A
|
28
+39%
|
31
+12%
|
32
+3%
|
|
| Change in Cash | ||||||||||||||
| Net Change in Cash |
(27)
N/A
|
(18)
+35%
|
27
N/A
|
48
+78%
|
(17)
N/A
|
(28)
-69%
|
4
N/A
|
(9)
N/A
|
(12)
-44%
|
(3)
+77%
|
5
N/A
|
11
+117%
|
7
-37%
|
|
| Free Cash Flow | ||||||||||||||
| Free Cash Flow |
(10)
N/A
|
(14)
-42%
|
(16)
-12%
|
(16)
-4%
|
(19)
-17%
|
(24)
-23%
|
(23)
+1%
|
(23)
+1%
|
(22)
+5%
|
(23)
-3%
|
(23)
N/A
|
(20)
+11%
|
(25)
-24%
|
|